N
Novatrials | Charlestown, Australia
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Maridebart Cafraglutide
Survodutide
BI 456906
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 2 total trials
Locations recently updated
This study is open to adults who are at least 18 years old and have a body mass index (BMI)bof 27 kg/m2 or more. People can take part if they have ca...
Active, not recruiting
Obesity
Drug: Placebo
Drug: survodutide
The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.
Enrolling
Obesity
Drug: Placebo
Drug: Maridebart Cafraglutide
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems